GlaxoSmithKline and McLaren agree five-year partnership

Drugs giant GlaxoSmithKline is to “rev up” its research and manufacturing operations through a tie-up with Formula 1 team McLaren.

The five-year partnership will see the two firms build a new £20m (€22.92m) research facility at McLaren’s headquarters in Woking, Surrey, with Glaxo sharing the F1 group’s expertise in engineering, analytics and modelling.